advertisement

---

Ahmed II 11

Showing records 1 to 11 | Display all abstracts from Ahmed II

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Vold S
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Christakis PG; Kalenak JW
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Ahmed II; Craven ER
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Tsai JC; Zurakowski D
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Mattox C; Stamper R
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Kammer JA; Harasymowycz PJ
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Packer M
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Mura JJ
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Brown RH; Ianchulev T
Ophthalmology 2016; 123: 2103-2112

---

70039 The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes
Cantor LB; Ahmed II
Ophthalmology 2016; 123: 2093-2102

---

69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts

Ophthalmology 2016; 123: 2103-2112

---